Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Experiences in fertility preservation: lessons learned to ensure that fertility and reproductive autonomy remain options for cancer survivors.

Noyes N, Melzer K, Druckenmiller S, Fino ME, Smith M, Knopman JM.

J Assist Reprod Genet. 2013 Oct;30(10):1263-70. doi: 10.1007/s10815-013-0066-2. Epub 2013 Aug 13.

2.

Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors.

Noyes N, Labella PA, Grifo J, Knopman JM.

J Assist Reprod Genet. 2010 Aug;27(8):495-9. doi: 10.1007/s10815-010-9434-3. Epub 2010 May 18.

3.

Successful Oocyte Cryopreservation in Reproductive-Aged Cancer Survivors.

Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N.

Obstet Gynecol. 2016 Mar;127(3):474-80. doi: 10.1097/AOG.0000000000001248.

PMID:
26855092
4.

Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.

Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N.

Hum Reprod. 2016 Mar;31(3):623-9. doi: 10.1093/humrep/dev325. Epub 2016 Jan 11.

PMID:
26759139
5.

Response to ovarian stimulation in patients facing gonadotoxic therapy.

Johnson LN, Dillon KE, Sammel MD, Efymow BL, Mainigi MA, Dokras A, Gracia CR.

Reprod Biomed Online. 2013 Apr;26(4):337-44. doi: 10.1016/j.rbmo.2013.01.003. Epub 2013 Jan 19.

6.

Does oocyte banking for anticipated gamete exhaustion influence future relational and reproductive choices? A follow-up of bankers and non-bankers.

Stoop D, Maes E, Polyzos NP, Verheyen G, Tournaye H, Nekkebroeck J.

Hum Reprod. 2015 Feb;30(2):338-44. doi: 10.1093/humrep/deu317. Epub 2014 Nov 28.

PMID:
25432922
7.

In vitro maturation of human immature oocytes for fertility preservation.

Chian RC, Uzelac PS, Nargund G.

Fertil Steril. 2013 Apr;99(5):1173-81. doi: 10.1016/j.fertnstert.2013.01.141. Epub 2013 Feb 20. Review.

PMID:
23433515
8.

Fertility preservation options in breast cancer patients.

Kasum M, von Wolff M, Franulić D, Čehić E, Klepac-Pulanić T, Orešković S, Juras J.

Gynecol Endocrinol. 2015;31(11):846-51. doi: 10.3109/09513590.2015.1081684. Epub 2015 Sep 15. Review.

PMID:
26370157
9.

Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.

Kim SY, Kim SK, Lee JR, Woodruff TK.

J Gynecol Oncol. 2016 Mar;27(2):e22. doi: 10.3802/jgo.2016.27.e22. Review.

10.

[Fertility preservation techniques in women of reproductive age ].

Vulliemoz N, Gaitzsch H, Primi M-P, Wunder D, Perey L, Streuli I.

Rev Med Suisse. 2014 Oct 22;10(447):1961-2, 1964-6, 1968. French.

PMID:
25518205
11.

Fertility after breast cancer treatment.

Kasum M, Beketić-Orešković L, Peddi PF, Orešković S, Johnson RH.

Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:13-8. doi: 10.1016/j.ejogrb.2013.11.009. Epub 2013 Nov 17. Review.

PMID:
24315568
12.

Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors.

Niemasik EE, Letourneau J, Dohan D, Katz A, Melisko M, Rugo H, Rosen M.

J Cancer Surviv. 2012 Sep;6(3):324-32. doi: 10.1007/s11764-012-0227-9. Epub 2012 Jul 3.

PMID:
22752834
13.

Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.

Hourvitz A, Yerushalmi GM, Maman E, Raanani H, Elizur S, Brengauz M, Orvieto R, Dor J, Meirow D.

Reprod Biomed Online. 2015 Oct;31(4):497-505. doi: 10.1016/j.rbmo.2015.06.025. Epub 2015 Jul 13.

PMID:
26278808
14.

Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.

Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.

Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4.

PMID:
26848188
15.

[Practical clinical aspects of oocyte vitrification for fertility preservation].

Courbiere B, Decanter C.

Gynecol Obstet Fertil. 2014 Sep;42(9):653-6. doi: 10.1016/j.gyobfe.2014.07.008. Epub 2014 Aug 20. French.

PMID:
25164159
16.

Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience.

Nurudeen SK, Douglas NC, Mahany EL, Sauer MV, Choi JM.

Am J Clin Oncol. 2016 Apr;39(2):154-9. doi: 10.1097/COC.0000000000000031.

PMID:
24441581
17.

Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.

Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE.

Fertil Steril. 2012 Nov;98(5):1225-8. doi: 10.1016/j.fertnstert.2012.07.1056. Epub 2012 Aug 9.

PMID:
22884018
18.

Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.

Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M.

Future Oncol. 2016 Jul;12(14):1731-41. doi: 10.2217/fon-2016-0095. Epub 2016 May 17. Review.

PMID:
27184037
19.

Variability in the practice of fertility preservation for patients with cancer.

Reynolds KA, Grindler NM, Rhee JS, Cooper AR, Ratts VS, Carson KR, Jungheim ES.

PLoS One. 2015 May 26;10(5):e0127335. doi: 10.1371/journal.pone.0127335. eCollection 2015.

20.

[Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].

Decanter C, Robin G.

Gynecol Obstet Fertil. 2013 Oct;41(10):597-600. doi: 10.1016/j.gyobfe.2013.08.007. Epub 2013 Oct 4. Review. French.

PMID:
24094596

Supplemental Content

Support Center